These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

737 related items for PubMed ID: 23158001

  • 1. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JÅ.
    Breast Cancer Res; 2012 Nov 16; 14(6):R148. PubMed ID: 23158001
    [Abstract] [Full Text] [Related]

  • 2. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z, Yang M, Chen R, Su W, Li P, Chen S, Chen Z, Chen A, Li S, Hu C.
    Oncogene; 2014 Jun 26; 33(26):3374-82. PubMed ID: 23975422
    [Abstract] [Full Text] [Related]

  • 3. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z, Jiao D, Qiao J, Yang S, Yan M, Cui S, Liu Z.
    Mol Cancer; 2015 May 14; 14():102. PubMed ID: 25972084
    [Abstract] [Full Text] [Related]

  • 4. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M, Lee ES, Hu G, Kang Y.
    J Biol Chem; 2008 May 30; 283(22):14910-4. PubMed ID: 18411277
    [Abstract] [Full Text] [Related]

  • 5. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT.
    J Nutr Biochem; 2015 Jun 30; 26(6):675-85. PubMed ID: 25792283
    [Abstract] [Full Text] [Related]

  • 6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W.
    Theranostics; 2019 Jun 30; 9(7):2036-2055. PubMed ID: 31037155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM, Sun W, Hua F, Xie J, Lin H, Zhou DD, Hu ZW.
    Cancer Lett; 2015 Sep 01; 365(2):190-200. PubMed ID: 26049022
    [Abstract] [Full Text] [Related]

  • 12. miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.
    Chang BP, Wang DS, Xing JW, Yang SH, Chu Q, Yu SY.
    J Huazhong Univ Sci Technolog Med Sci; 2014 Apr 01; 34(2):201-206. PubMed ID: 24710933
    [Abstract] [Full Text] [Related]

  • 13. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
    Karihtala P, Auvinen P, Kauppila S, Haapasaari KM, Jukkola-Vuorinen A, Soini Y.
    Breast Cancer Res Treat; 2013 Feb 01; 138(1):81-90. PubMed ID: 23412770
    [Abstract] [Full Text] [Related]

  • 14. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
    Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W, Sarkar FH, Raz A.
    Cancer Res; 2011 May 01; 71(9):3400-9. PubMed ID: 21389093
    [Abstract] [Full Text] [Related]

  • 15. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ.
    Nat Cell Biol; 2008 May 01; 10(5):593-601. PubMed ID: 18376396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG.
    Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057
    [Abstract] [Full Text] [Related]

  • 18. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X, Ding X, Li X, Gao S, Yang Q.
    Cancer Sci; 2015 Aug 13; 106(8):982-9. PubMed ID: 26011542
    [Abstract] [Full Text] [Related]

  • 19. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.
    Carcinogenesis; 2013 Apr 13; 34(4):874-84. PubMed ID: 23275155
    [Abstract] [Full Text] [Related]

  • 20. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G.
    Oncogene; 2014 Mar 06; 33(10):1325-35. PubMed ID: 23474752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.